These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29741504)

  • 1. Research in drug development for advanced prostate cancer.
    Eisenberger M
    Clin Adv Hematol Oncol; 2018 Jan; 16(1):42-44. PubMed ID: 29741504
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
    Tunn UW; Goldschmidt AJ; Peter K; Becker M
    Prog Clin Biol Res; 1990; 359():165-76; discussion 177-80. PubMed ID: 2149458
    [No Abstract]   [Full Text] [Related]  

  • 3. Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases.
    Eisenkraft S; Huben RP; Pontes JE
    Urology; 1984 Jun; 23(6 Suppl):51-3. PubMed ID: 6539524
    [No Abstract]   [Full Text] [Related]  

  • 4. [New perspectives in the drug therapy of hormone-resistant prostate cancer].
    Vorob'ev NA; Nosov AK; Vorob'ev AV; Moiseenko VM
    Vopr Onkol; 2010; 56(6):645-53. PubMed ID: 21395118
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.
    Taneja SS
    J Urol; 2014 Mar; 191(3):656. PubMed ID: 24522033
    [No Abstract]   [Full Text] [Related]  

  • 6. Abiraterone acetate and its use in the treatment of metastatic prostate cancer: a review.
    Caffo O; Veccia A; Kinspergher S; Maines F
    Future Oncol; 2018 Feb; 14(5):431-442. PubMed ID: 29350549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of advanced prostate cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1986 Jan; 79(1):33-9. PubMed ID: 2938361
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of advanced cancer of the prostate.
    Wirth MP
    Prog Clin Biol Res; 1990; 350():159-70. PubMed ID: 2201042
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer.
    Petrioli R; Fiaschi AI; Francini E; Pascucci A; Francini G
    Cancer Treat Rev; 2008 Dec; 34(8):710-8. PubMed ID: 18620815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stanford experience with chemotherapy for metastatic prostate cancer.
    Torti FM; Reese J; Freiha F
    Prog Clin Biol Res; 1990; 350():171-85. PubMed ID: 1696740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advanced prostate cancer--a therapeutic dilemma?].
    Rübben H; Altwein JE
    Urologe A; 1987 Jan; 26(1):7-14. PubMed ID: 3576864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer chemotherapy: emerging from the shadows.
    Roth BJ
    J Clin Oncol; 2005 May; 23(15):3302-3. PubMed ID: 15738529
    [No Abstract]   [Full Text] [Related]  

  • 13. An unusual presentation of a varicella zoster virus encephalitis in a patient treated for metastatic prostate cancer.
    Rhodius-Meester HF; Kuper IM; Otten HM; Hamburger HL
    J Am Geriatr Soc; 2010 Dec; 58(12):2437-8. PubMed ID: 21143452
    [No Abstract]   [Full Text] [Related]  

  • 14. The evolving role of chemotherapy in prostate cancer.
    Boulos S; Mazhar D
    Future Oncol; 2017 May; 13(12):1091-1095. PubMed ID: 28095710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AUO study AP 59/10: first-line therapy of castration-resistant prostate cancer].
    Rexer H
    Urologe A; 2011 Jun; 50(6):722-4. PubMed ID: 21584827
    [No Abstract]   [Full Text] [Related]  

  • 16. In focus: prostate cancer.
    Clin Adv Hematol Oncol; 2003 May; 1(5):271. PubMed ID: 16235417
    [No Abstract]   [Full Text] [Related]  

  • 17. New agents in the therapy of hormone-refractory patients with prostate cancer.
    Kantoff PW
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):32-4. PubMed ID: 7532323
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiopharmaceutical and chemotherapy combinations in metastatic castrate-resistant prostate cancer: a new beginning?
    Sartor O
    J Clin Oncol; 2009 May; 27(15):2417-8. PubMed ID: 19364953
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of hormone refractory prostate carcinoma].
    Wirth MP; Nippgen J
    Urologe A; 2003 Nov; 42(11):1453-60. PubMed ID: 14624343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting metastatic prostate cancer: the search for innovative systemic therapies.
    Berthold DR; Moore MJ
    Oncology (Williston Park); 2006 Dec; 20(14):1787-91; discussion 1791-6. PubMed ID: 17263128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.